MGO One Seven’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Buy |
1,822
+43
| +2% | +$19.1K | 0.03% | 559 |
|
|
2025
Q1 | $862K | Sell |
1,779
-3,963
| -69% | -$1.92M | 0.03% | 470 |
|
|
2024
Q4 | $2.31M | Buy |
5,742
+2,336
| +69% | +$941K | 0.09% | 248 |
|
|
2024
Q3 | $1.58M | Buy |
3,406
+185
| +6% | +$86K | 0.07% | 289 |
|
|
2024
Q2 | $1.51M | Buy |
3,221
+1,598
| +98% | +$749K | 0.07% | 276 |
|
|
2024
Q1 | $678K | Buy |
1,623
+404
| +33% | +$169K | 0.04% | 442 |
|
|
2023
Q4 | $496K | Buy |
1,219
+406
| +50% | +$165K | 0.03% | 531 |
|
|
2023
Q3 | $283K | Sell |
813
-122
| -13% | -$42.4K | 0.02% | 634 |
|
|
2023
Q2 | $329K | Sell |
935
-377
| -29% | -$133K | 0.03% | 563 |
|
|
2023
Q1 | $413K | Buy |
1,312
+109
| +9% | +$34.3K | 0.03% | 538 |
|
|
2022
Q4 | $347K | Buy |
1,203
+234
| +24% | +$67.6K | 0.03% | 508 |
|
|
2022
Q3 | $519 | Buy |
969
+82
| +9% | +$44 | 0.02% | 381 |
|
|
2022
Q2 | $250K | Sell |
887
-75
| -8% | -$21.1K | 0.03% | 517 |
|
|
2022
Q1 | $251K | Buy |
+962
| New | +$251K | 0.03% | 555 |
|
|
2019
Q1 | – | Sell |
-195
| Closed | -$32K | – | 1614 |
|
|
2018
Q4 | $32K | Buy |
+195
| New | +$32K | 0.01% | 769 |
|
|
2018
Q1 | $33K | Sell |
201
-4
| -2% | -$657 | 0.02% | 722 |
|
|
2017
Q4 | $31K | Buy |
+205
| New | +$31K | 0.01% | 749 |
|